Our work focuses on development of magnetic resonance (MR) technology in identifcation of the functional and metabolic changes that precede anatomic evidence of cancer disease, tracking gene expression, studying drug delivery and response, and monitoring basic cellular processes.
Preclinical Models
Clinical Imaging
MR Metabolomics
Data Analysis
For MR Cancer related issues please contact Tone F. Bathen or Ingrid S. Gribbestad.
The MR Cancer group is physically located at the MR Center, next to the Cancer Department at St. Olavs University Hospital in Trondheim.